Drug Discovery Opinion

Sphingosine-1-phosphate (S1P), the product of phosphorylation of sphingosine by sphingosine kinase, is an important lipid signalling molecule for which biological functions continue to be defined. A new study by researchers working at the National Institute of Allergy and Infectious Diseases (NIAID) has now demonstrated a key role for S1P in bone remodelling. This process involves two major types of bone cells: osteoclasts, which break down bone and osteoblasts, which make new bone. Bone resorption and bone formation are normally finely balanced but, in conditions such as osteoporosis and rheumatoid arthritis, osteoclast activity exceeds osteoblast activity leading to a net decrease in bone density.

Immature osteoclasts circulate within the blood and migrate to the surface of the bones, where they mature and start to degrade the bone matrix. These immature cells were shown to express functional S1P₁ receptors and migrate along an S1P gradient in vitro. Specialised imaging techniques were used to show that the S1P₁ agonist, SEW2871, also stimulated motility in vivo. In a mouse model of postmenopausal osteoporosis, treatment of ovariectomized mice with the S1P₁ agonist, FTY720, reduced osteoporosis by reducing the number of mature osteoclasts attached to the bone surface. FTY720 also acts as an immunosuppressant by preventing egress of lymphocytes from the lymph nodes, and is undergoing phase III clinical trials for the treatment of relapsing-remitting multiple sclerosis.

Most current treatments for osteoporosis target mature osteoclasts, and regulating migration of immature osteoclasts to the bone surface may offer a new approach to treating the disease.

The study, published in the journal Nature, was available online on February 8^th.

Bookmark It

Hide Sites

Related posts:

1. Role for Oxytocin in Bone Remodelling Research recently published in the journal PNAS describes a new role for the hormone, oxytocin. This nine-residue peptide is best...
2. Serotonin Found to Regulate Bone Growth Bone is living growing tissue and is remodelled constantly throughout life. The process involves two major types of bone cells:...
3. New Role for Immune System in Osteoporosis Many reports have linked high cholesterol with osteoporosis and HMG-CoA reductase inhibitors (statins) have been proposed to reduce the risk...
4. And the Thigh Bone’s Connected to…. ….not the skull bone, according to researchers in the UK led by scientists at Queen Mary, University of London. Writing...
5. Arrestin’ Osteoporosis Osteoporosis is the result of an imbalance between bone resorption and bone formation in the constant matrix remodelling process that...

Related posts brought to you by Yet Another Related Posts Plugin.

 Email This Post

This entry was posted on Thursday, February 12th, 2009 at 8:30 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.